ENDRA Life Sciences (NDRA) Depreciation & Amortization (CF) (2016 - 2025)
ENDRA Life Sciences has reported Depreciation & Amortization (CF) over the past 6 years, most recently at $21261.0 for Q4 2021.
- Quarterly Depreciation & Amortization (CF) fell 60.79% to $21261.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $116238.0 through Dec 2021, up 17.01% year-over-year, with the annual reading at $44045.0 for FY2025, 5.26% down from the prior year.
- Depreciation & Amortization (CF) was $21261.0 for Q4 2021 at ENDRA Life Sciences, down from $29823.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $54228.0 in Q4 2020 and troughed at $1100.0 in Q3 2020.
- The 5-year median for Depreciation & Amortization (CF) is $19999.5 (2018), against an average of $21297.7.
- Year-over-year, Depreciation & Amortization (CF) tumbled 94.48% in 2020 and then skyrocketed 2611.18% in 2021.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $15360.0 in 2017, then skyrocketed by 30.66% to $20070.0 in 2018, then rose by 4.16% to $20904.0 in 2019, then soared by 159.41% to $54228.0 in 2020, then tumbled by 60.79% to $21261.0 in 2021.
- Per Business Quant, the three most recent readings for NDRA's Depreciation & Amortization (CF) are $21261.0 (Q4 2021), $29823.0 (Q3 2021), and $33729.0 (Q2 2021).